Chiropractors in Buckley, WA Accepting Medicare
5 Chiropractors found. Showing 1 - 5
 Dr. William P Loomis, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 500 Main St., Buckley, WA 98321 Phone: 360-829-0610 Fax: 360-829-6359 |
 Alpine Sports Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 766 Main St, Buckley, WA 98321 Phone: 253-740-6127 |
 Dr. Kristina Michelle Mahan-sawvell, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 500 Main St, Buckley, WA 98321 Phone: 360-829-0610 Fax: 360-829-6354 |
Dr. Michael Leigh Beall, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 766 Main St, Buckley, WA 98321 Phone: 253-740-6127 |
Dr. Daniel James Mcnabb, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 135 Jefferson Ave, Suite L, Buckley, WA 98321 Phone: 360-829-2125 Fax: 360-829-5313 |
News Archive
Adjuvant therapy may not improve survival for rare cancers
A recent study found that adjuvant therapy following surgical removal of a rare form of gastrointestinal tumor has no effect on survival rates for patients.
Researchers identify potential therapeutic target in treatment of certain AML
Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.
Biotime ships six ACTCellerate progenitor cell lines to Millipore
BioTime, Inc. announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks.
New test to assess viral load of cytomegalovirus
Roche announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for solid organ transplantation.
GHIT Fund announces new grants to tackle malaria, chagas disease and dengue
The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced seven grant investments totaling US$15.3 million to speed the development of promising drugs and vaccines to battle three insect-borne diseases-malaria, dengue and Chagas disease.
› Verified 3 days ago
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Physical Therapists